NODAL MARGINAL ZONE B-CELL LYMPHOMA

This adverse event was reported 34 times

NODAL MARGINAL ZONE B-CELL LYMPHOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OXAPROZIN 1 0.0011
1 ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE 1 0.0011
2 OMEPRAZOLE 20MG 1 0.0009
3 CLORAZEPATE DIPOTASSIUM 1 0.0005
4 ALENDRONATE SODIUM AND CHOLECALCIFEROL 1 0.0004
5 CALCIPOTRIENE 1 0.0003
6 POTASSIUM CITRATE 1 0.0002
7 ROMIPLOSTIM 2 0.0001
8 ATOVAQUONE 1 0.0001
9 VANCOMYCIN HYDROCHLORIDE 1 0.0001
See all drugs enriched for association with NODAL MARGINAL ZONE B-CELL LYMPHOMA

NODAL MARGINAL ZONE B-CELL LYMPHOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 1 0.0005
1 Thrombopoietin Receptor Agonist [EPC] 2 0.0001
2 Antimalarial [EPC] 1 0.0001
3 Antiprotozoal [EPC] 1 0.0001
4 Prostaglandin E1 Analog [EPC] 1 0.0001
5 Vitamin D Analog [EPC] 1 0.0001
6 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
7 Human Immunoglobulin G [EPC] 1 0.0000
8 Progesterone [EPC] 1 0.0000
9 Alkaloid [EPC] 1 0.0000
See all drug classes enriched for association with NODAL MARGINAL ZONE B-CELL LYMPHOMA